GlassScriptPhysician profile
Brandon W King
NPI 1194046953
$25,356.17
in general payments reported to CMS, 2019-2025
11 companies · $11K in 2025
The $11K reported for 2025 was more than what 88% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,425 · 2020: $324 · 2021: $3,462 · 2022: $4,354 · 2023: $1,397 · 2024: $3,421 · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $8,313 · Food and Beverage: $3,471 · Travel and Lodging: $3,422 · Education: $586.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $8,312.50 |
| Food and Beverage | $3,471.04 |
| Travel and Lodging | $3,422.22 |
| Education | $586.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $12,851.60 | 2021-2025 | Prostep, Inbone, Infinity |
| Pinnacle, INC | $4,550.82 | 2021-2025 | |
| Heron Therapeutics, INC. | $2,030.00 | 2021 | |
| Paragon 28, INC. | $1,905.94 | 2019-2025 | Portfolio, Additive Orthopedics, Apex 3d |
| Alphatec Spine, INC | $1,719.16 | 2022 | |
| Wright Medical Technology, INC. | $1,432.57 | 2019-2020 | |
| Depuy Synthes Sales INC. | $286.18 | 2019-2025 | Dynaforce |
| Arthrex, INC. | $252.08 | 2023 | |
| Treace Medical Concepts, INC. | $221.54 | 2022-2024 | |
| Orthofix Medical, INC. | $62.77 | 2019 | |
| Zimmer Biomet Holdings, INC. | $43.51 | 2025 | Tapestry |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandon King listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.